STERIS'S ISMN 40 Mg : Uses, Dosage, Side Effects, Price, Composition and More.

STERIS'S ISMN 40 Mg

Isosorbide Mononitrate SR (40 mg)

STERIS's ISMN 40, containing Isosorbide Mononitrate SR 40 mg, is a medication primarily used to treat angina pectoris, a condition characterized by chest pain or discomfort due to coronary artery disease. It works by dilating blood vessels, improving blood flow to the heart, and reducing the workload on the heart muscles.

Dosage:

The recommended starting dose of ISMN 40 is usually 20 mg to 40 mg once daily, preferably in the morning. The dosage may be adjusted based on individual response and tolerance, under the guidance of a healthcare professional. The tablet should be swallowed whole with a full glass of water, and it's important not to crush or chew it.

Key Features and Benefits:

1. Extended-Release Formulation: ISMN 40 is formulated as a sustained-release tablet, providing continuous and prolonged action over 24 hours with a single daily dose. This extended duration of action ensures consistent protection against angina episodes.

2. Improved Exercise Tolerance: By enhancing blood flow to the heart, ISMN 40 helps improve exercise capacity and reduces the frequency and severity of angina attacks during physical activity. This can lead to a better quality of life for individuals with coronary artery disease.

3. Nitrate Tolerance Management: ISMN 40 is designed to minimize the development of nitrate tolerance, a phenomenon where the body becomes less responsive to nitrate medications over time. This helps maintain the drug's efficacy and reduces the need for dose adjustments.

4. Convenient Dosage Regimen: With once-daily dosing, ISMN 40 offers convenience and ease of use for patients, promoting better medication adherence and ensuring consistent therapeutic effects.

5. Well-Tolerated: ISMN 40 is generally well-tolerated, with common side effects such as headache, dizziness, and flushing being mild and transient. reported to a healthcare provider.

Precautions and Considerations:

• Patients with severe hypotension (low blood pressure) should use ISMN 40 with caution, as it can further lower blood pressure.
• Avoid sudden discontinuation of ISMN 40 without medical advice, as it may lead to rebound angina or worsening of symptoms.
• Inform your healthcare provider about all medications, including over-the-counter drugs and supplements, to avoid potential drug interactions.
• Pregnant or breastfeeding individuals should consult their healthcare provider before using ISMN 40, as its safety during these periods may need evaluation.

Conclusion:

STERIS's ISMN 40 (Isosorbide Mononitrate SR 40 mg) is a valuable medication for managing angina pectoris associated with coronary artery disease. Its extended-release formulation, efficacy in improving exercise tolerance, and favorable safety profile make it a preferred choice for long-term angina management. However, it's crucial to use ISMN 40 under medical supervision and adhere to prescribed dosages for optimal therapeutic benefits and safety. A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology.  

 For further information: 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

  BUY NOW